Is Ingevity (NGVT) overvalued or fairly valued?

MarketChacha shows Ingevity's valuation in context — a forward P/E of about 11.8, a price-to-book of about 52.1 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Ingevity's revenue?

Ingevity reported revenue of $1.2B for FY2025, with net profit of $-167.1M, per official filings.

What is the share price of Ingevity (NGVT)?

Ingevity last traded at $70.75 (+0.6% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

Ingevity

NGVT · NYSE · Materials · United States

Snapshot

TickerNGVT

ExchangeNYSE

SectorMaterials

IndustrySpecialty Chemicals

CountryUnited States

Employees1,400

HeadquartersNorth Charleston, United States

Websitewww.ingevity.com

Filings tracked21

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Who owns it

Insiders0.8%
Institutions99.2%
Public & other0.0%

438 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.15.60%
Vanguard Portfolio Management LLC6.91%
Vanguard Capital Management LLC4.57%
State Street Corporation4.36%
American Century Companies Inc3.70%
Wellington Management Group, LLP3.13%
Segall Bryant & Hamill, LLC3.07%
Millennium Management Llc2.89%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Margin has compressed by about 13.9 points over the period — profitability is trending down.

Net margin trend-0.4% → -14.3%

Margin has compressed by about 13.9 points over the period — profitability is trending down.

Return on equity-562.6%

Latest ROE of -562.6% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $242.9M · EPS 0.90

Est. earnings growth +43.4%

Next fiscal year

Rev $1.1B · EPS 6.01

Est. earnings growth +14.7%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$1.2B

Net margin

-14.3%

ROE

-562.6%

Revenue CAGR (2y)

-2.0%

EPS (FY2025)

-4.61

Net profit (FY2025)

$-167.1M

Ask MarketChacha about NGVT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$1.2B	$-167.1M	-4.61	-14.3%	-562.6%
FY2024	$1.2B	$-430.3M	-11.85	-35.9%	-220.4%
FY2023	$1.2B	$-5.4M	-0.15	-0.4%	-0.9%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$314.1M	$35.3M	1.00	11.2%
2026Q1	$258.0M	$59.8M	1.66	23.2%
2025Q3	$333.1M	$43.5M	1.18	13.1%
2025Q2	$331.5M	$-146.5M	-4.02	-44.2%
2025Q1	$247.9M	$20.5M	0.56	8.3%
2024Q3	$333.8M	$-107.2M	-2.94	-32.1%
2024Q2	$390.6M	$-283.7M	-7.81	-72.6%
2024Q1	$340.1M	$-56.0M	-1.54	-16.5%
2023Q3	$446.0M	$25.2M	0.69	5.7%
2023Q2	$481.8M	$35.5M	0.97	7.4%
2023Q1	$392.6M	$50.7M	1.35	12.9%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC7/30/2026
8-K — Results of operations, Exhibits
SEC7/29/2026material
8-K — Executive/director change, Exhibits
SEC6/24/2026material
10-Q filing
SEC5/7/2026
8-K — Results of operations, Exhibits
SEC5/6/2026material
8-K — Executive/director change, Shareholder vote results, Exhibits
SEC5/4/2026material
8-K — Reg FD disclosure, Exhibits
SEC4/15/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC3/30/2026material
10-K filing
SEC2/26/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC2/25/2026material
8-K — Executive/director change, Exhibits
SEC2/23/2026material
8-K — Material agreement, Completion of acquisition/disposition, Reg FD disclosure, Exhibits
SEC1/5/2026material

2025

8-K — Reg FD disclosure, Exhibits
SEC12/8/2025material
8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC12/8/2025material
8-K — Reg FD disclosure, Exhibits
SEC12/1/2025material
10-Q filing
SEC11/6/2025
8-K — Results of operations, Exhibits
SEC11/5/2025material
8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC10/23/2025material
8-K — Material agreement, Reg FD disclosure, Exhibits
SEC9/4/2025material
10-Q filing
SEC8/5/2025
8-K — Results of operations, Exhibits
SEC8/4/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.